• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴刀豆球蛋白A激活的、Lyt选择的亚群在含白细胞介素-2的上清液中的生长。

The growth of concanavalin-A activated, Lyt selected subsets in IL-2 containing supernatants.

作者信息

Kuppers R C, Simon M M, Eichmann K

出版信息

Immunobiology. 1984 Oct;167(4):365-75. doi: 10.1016/S0171-2985(84)80008-X.

DOI:10.1016/S0171-2985(84)80008-X
PMID:6334647
Abstract

The growth properties of Con A activated, Lyt selected splenic T lymphocytes were examined by limiting dilution analysis and clonally by single cell picking. Under the conditions used, a comparable frequency of Lyt 1+ and Lyt 2+ cells grew after Con A activation in the presence of Con A rat spleen supernatant. At a clonal level, however, the growth of these subsets differed qualitatively and quantitatively. While Lyt 2+ cells obtained clone sizes of several hundred cells, Lyt 1+ clone sizes were usually less than 100 cells, and many clones aborted their growth after a few days. Morphologically, the Lyt 1+ cell was smaller and usually showed fewer pseudopodial protusions as compared to the Lyt 2+ cell.

摘要

通过有限稀释分析并通过单细胞挑选进行克隆,研究了伴刀豆球蛋白A(Con A)激活、Lyt分型的脾T淋巴细胞的生长特性。在所使用的条件下,在Con A大鼠脾上清液存在的情况下,Con A激活后,Lyt 1 +和Lyt 2 +细胞的生长频率相当。然而,在克隆水平上,这些亚群的生长在质量和数量上有所不同。虽然Lyt 2 +细胞获得了数百个细胞的克隆大小,但Lyt 1 +克隆大小通常小于100个细胞,并且许多克隆在几天后停止生长。形态学上,与Lyt 2 +细胞相比,Lyt 1 +细胞更小,通常显示出较少的伪足突起。

相似文献

1
The growth of concanavalin-A activated, Lyt selected subsets in IL-2 containing supernatants.伴刀豆球蛋白A激活的、Lyt选择的亚群在含白细胞介素-2的上清液中的生长。
Immunobiology. 1984 Oct;167(4):365-75. doi: 10.1016/S0171-2985(84)80008-X.
2
Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.在伴刀豆球蛋白A刺激后,经阳性选择的Lyt-2⁺和Lyt-2⁻小鼠T淋巴细胞在白细胞介素2以及作用于B细胞、巨噬细胞和肥大细胞的淋巴因子释放方面相当,但在干扰素产生方面存在差异。
J Immunol. 1983 May;130(5):2225-30.
3
Interleukin 2 induces both, growth and maturation of lectin reactive Lyt-2+ but not Lyt-2-precursor cells and regulates the cytolytic potential of effector cells.白细胞介素2可诱导凝集素反应性Lyt-2+细胞而非Lyt-2-前体细胞的生长和成熟,并调节效应细胞的细胞溶解潜能。
Immunobiology. 1986 Apr;171(3):274-301. doi: 10.1016/S0171-2985(86)80010-9.
4
Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.白细胞介素2对T淋巴细胞淋巴因子分泌的增强作用:对已建立的克隆和原代有限稀释微量培养物的分析。
J Immunol. 1984 Jun;132(6):2932-8.
5
Con A-induced TCGF-reactivity is selectively acquired by Lyt-2-positive T cell precursors.刀豆球蛋白A诱导的TCGF反应性是由Lyt-2阳性T细胞前体选择性获得的。
J Immunol. 1983 Jul;131(1):19-22.
6
Lyt-2+ cells. Requirements for concanavalin A-induced proliferation and interleukin 2 production.Lyt-2+细胞。刀豆球蛋白A诱导增殖及白细胞介素2产生的条件。
J Immunol. 1987 Nov 1;139(9):2880-7.
7
Production of interleukin 2, interleukin 3, and interferon by mouse T lymphocyte clones of Lyt-2+ and -2- phenotype.Lyt-2 +和-2-表型的小鼠T淋巴细胞克隆产生白细胞介素2、白细胞介素3和干扰素。
J Immunol. 1984 Apr;132(4):1869-71.
8
IL 2 production by mitogen-stimulated T cell subsets: helper-precursors are predominantly Lyt-2-.
J Immunol. 1983 Dec;131(6):2864-7.
9
Activation of Lyt-1+ and Lyt-2+ T cell cloned lines: stimulation of proliferation, lymphokine production, and self-destruction.Lyt-1+和Lyt-2+ T细胞克隆系的激活:对增殖、淋巴因子产生及自我破坏的刺激作用。
J Immunol. 1985 Apr;134(4):2185-90.
10
A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.一种大鼠抗小鼠T4单克隆抗体(H129.19)可抑制Ia反应性T细胞克隆的增殖,并在抗Ia细胞毒性T细胞克隆中区分出两个表型不同的亚群(T4+、Lyt-2,3-和T4-、Lyt-2,3+)。
J Immunol. 1984 Jun;132(6):2775-82.